Canada

Bavarian Nordic enters smallpox vaccine contract with Canadian government

07-Jun-2022 By Rachel Arthur

The Public Health Agency of Canada (PHAC) will purchase Bavarian Nordic’s smallpox vaccine Imvamune in a five-year contract worth around $56m.

Plant-based COVID-19 vaccine approved in Canada

28-Feb-2022 By Rachel Arthur

Medicago and GlaxoSmithKline (GSK) have gained approval for Covifenz, the companies’ plant-based COVID-19 vaccine, from Health Canada.

Moderna secures extended vaccine supply with Canada, sees regulatory advances

19-Aug-2021 By Jane Byrne

The last week has seen a plethora of announcements linked to Moderna’s mRNA COVID-19 shot.

Precision NanoSystems eyes 2022 completion date for new genetic medicine GMP biomanufacturing center in Vancouver

12-Aug-2021 By Rachel Arthur

The new facility will be home to Precision NanoSystems’s new global headquarters and include multiple GMP suites for manufacturing RNA therapeutics and vaccines.

Moderna to build mRNA vaccine manufacturing facility in Canada

11-Aug-2021 By Rachel Arthur

Moderna has signed a Memorandum of Understanding with the government of Canada to build a mRNA vaccine manufacturing facility in the country: which could serve as a model for similar partnerships around the world.

Ocugen and Jubilant HollisterStier in manufacturing partnership for COVID-19 vaccine candidate

15-Jun-2021 By Rachel Arthur

Ocugen has chosen Jubilant HollisterStier of Spokane, Washington as its manufacturing partner for COVID-19 vaccine candidate COVAXIN, ready for potential commercial manufacture for the US and Canadian markets.

AstraZeneca COVID-19 vaccine age limits: France will now use the vaccine for ages 65 plus - but Canada won’t

02-Mar-2021 By Rachel Arthur

This week France has raised the age limit for the AstraZeneca COVID-19 vaccine; but Canada, conversely, has put a 65-year-old limit into its recommendations.

BD receives order for 177m syringes from US and Canada

27-Jul-2020 By Ben Hargreaves

US and Canadian governments enter deal for needles and syringes to deliver potential COVID-19 vaccine.

Biologics access threatened by US-Mexico-Canada agreement, says biosimilar industry

03-Oct-2018 By Flora Southey

The US, Mexico and Canada have agreed a trade deal that includes 10 years of data protection for biologics.

How the US-Mexico trade deal could impact the biologics market

17-Sep-2018 By Ben Hargreaves

BioPharma-Reporter (BPR) discusses with Jennifer Fox (JF), co-chair of Brinks Gilson & Lione’s biopharma practice group, the provisional detail revealed from the US administration’s proposed trade deal with Mexico, and its potential impact on the...